Report Highlights
For years, coastal consumers have enjoyed access to healthy foods, easily stumbling upon kombucha or probiotic-filled chocolates in trendy, niche boutiques and health food stores. This past year, we've seen larger corporations embrace wellness, starting a strong ripple effect and bringing better food at better prices to grocery stores across the country. These moves indicate a strong interest in millennials, a demographic with an estimated $1 trillion of buying power who are more dedicated to eating well and supporting ethical, sustainable business practices with their dollars than any other generation.
Report Includes
- An overview of the health food industry and discussion about their growing need
- Knowledge about oats as a healthy alternative and information on kombucha or probiotic-filled chocolates
- Information on GMO free products and their benefits
- Comparative study of traditional health food, modern health food and functional health food
- Insight into government programs and policies in support of health food usage
Analyst Credentials
The analyst of this report, Smruti Munshi, has specialized in the medical technologies space for more than five years. She focuses on monitoring and analyzing emerging trends, technologies, competitive benchmarking and market dynamics in the medical imaging industry. She has worked on several projects spanning the EMEA markets, ranging from market insights, industry overviews, to comprehensive marketing and technology-oriented custom consulting. Ms. Munshi has an M.S. in Biomedical Engineering and a B.S. in Instrumentation and Control Engineering. She has authored several reports for BCC Research in the medical field.
Related Reports
Nutraceuticals: Global Markets
The global market for nutraceuticals is expected to grow from $418.2 billion in 2024 and is projected to reach $571.3 billion by the end of 2029, at a compound annual growth rate (CAGR) of 6.4% during the forecast period of 2024 to 2029.
Personalized Nutrition: Global Markets
The global personalized nutrition market reached $23.5 billion in 2022 and should reach $48.2 billion by 2028, with a compound annual growth rate (CAGR) of 12.5% during the forecast period of 2023-2028.
2019 Food and Beverage Research Review
This Food Research Review provides a sampling of the type of quantitative market information, analysis and guidance. It includes the highlights of reports published in 2019 on the food and beverage markets.
Whey Protein Products: North American Markets
North American market for whey protein products will grow from $7.3 billion in 2018 to $10.2 billion by 2023 with a compound annual growth rate (CAGR) of 6.8% for the period of 2018-2023.
Recent Reports
Conventional and Alternative Pain Treatment Markets
The global market for conventional and alternative pain treatment is expected to grow from $96.2 billion in 2024 and is projected to reach $144.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.4% during the forecast period of 2024 to 2029.
CRISPR Technology: Global Markets
The global market for CRISPR technology was valued at $3.4 billion in 2023. This market is expected to grow from $3.8 billion in 2024 to $7.5 billion by the end of 2029, at a compound annual growth rate (CAGR) of 14.4% from 2024 to 2029.
Chronic Disease Management: Therapeutics, Device Technologies and Global Markets
The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.
Medical Devices: Technologies and Global Markets
The global market for medical devices reached $739.6 billion in 2023. It is expected to grow from $810.4 billion in 2024 to $1.3 trillion by the end of 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Point-of-Care Diagnostics: Technologies and Global Markets
The global market for point-of-care diagnostics was valued at $36.9 billion in 2023. It is expected to grow from $40.6 billion in 2024 to $65.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 10.2% from 2024 through 2029.
Top Trending Reports
AI in Clinical and Molecular Diagnostics Market
The global market for AI in clinical and molecular diagnostics is expected to grow from $2.6 billion in 2024 and is projected to reach $8.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 27.6% during the forecast period of 2024 to 2029.
Point-of-Care Diagnostics: Technologies and Global Markets
The global market for point-of-care diagnostics was valued at $36.9 billion in 2023. It is expected to grow from $40.6 billion in 2024 to $65.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 10.2% from 2024 through 2029.
Medical Devices: Technologies and Global Markets
The global market for medical devices reached $739.6 billion in 2023. It is expected to grow from $810.4 billion in 2024 to $1.3 trillion by the end of 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
CRISPR Technology: Global Markets
The global market for CRISPR technology was valued at $3.4 billion in 2023. This market is expected to grow from $3.8 billion in 2024 to $7.5 billion by the end of 2029, at a compound annual growth rate (CAGR) of 14.4% from 2024 to 2029.
Global Artificial Intelligence (AI) Market: Investments vs Potential
The global market for artificial intelligence (AI) is estimated to increase from $148.8 billion in 2023 to reach $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 39.7% from 2024 through 2029.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More